Status:
COMPLETED
Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy Subjects
Lead Sponsor:
University of California, San Diego
Conditions:
Endothelial Dysfunction
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The objective of this study is to show that Ezetimibe will improve endothelial function following high cholesterol meals in healthy subjects by decreasing absorption of cholesterol and thus affecting ...
Detailed Description
24 subjects will be recruited. Exclusion criteria will be presence of known metabolic syndrome as well as history of coronary artery disease, hypertension, diabetes, cardiomyopathy and tobacco use. St...
Eligibility Criteria
Inclusion
- healthy adults over 18 yrs of age
Exclusion
- presence of known metabolic syndrome
- as history of coronary artery disease
- hypertension
- diabetes
- cardiomyopathy
- tobacco use
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00376246
Start Date
September 1 2006
End Date
April 1 2008
Last Update
February 12 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.